SCHUBERT GERD
No ORCID on file
· 135 papers in corpus
· active 1998-2009
Frequent coauthors
- ELGER Walter 90
- CHWALISZ Kristof 90
- TORNUS Ingo 30
- BERTRAM GUDRUN 15
- KASCH HELMUT 15
- MENZENBACH BERND 15
- PONSOLD KURT 15
- ROHRIG HEIDEMARIE 15
- KAUFMANN Günter 15
- KURISCHKO ANATOLI 15
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2009
The invention relates to the use of an effective amount of mesoprogestins of the types J867, J912, J956 and J1042 for preparing a composition for the treatment of benign hormone-dependent gynecological disorders, such as endometriosis, uter…
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …
2008
This present invention disclosed the use of mesoprogestins, a new class of progesterone receptor modulators (PRMs), for the treatment and prevention of benign hormone dependent gynecological disorders: a) for the treatment of gynecological …